A high-throughput response to the SARS-CoV-2 pandemic

被引:3
作者
Rasmussen, Lynn [1 ]
Sanders, Shalisa [1 ]
Sosa, Melinda [1 ]
Mckellip, Sara [1 ]
Nebane, N. Miranda [1 ]
Martinez-Gzegozewska, Yohanka [1 ]
Reece, Andrew [1 ]
Ruiz, Pedro [1 ]
Manuvakhova, Anna [1 ]
Zhai, Ling [1 ]
Warren, Brooke [1 ]
Curry, Aliyah [1 ]
Zeng, Qinghua [1 ]
Bostwick, J. Robert [1 ]
Vinson, Paige N. [1 ]
机构
[1] Southern Res, Birmingham, AL 35294 USA
关键词
SARS-CoV-2; SARS; SARS2; SARS-CoV; MERS; COVID; COVID-19; Pandemic; Antiviral; High-throughput; HTS; BSL-3; Coronavirus; Drug discovery; RESPIRATORY SYNCYTIAL VIRUS; INHIBITORS; IDENTIFICATION; REPLICATION; DISCOVERY; LIBRARY; SCREEN; ASSAYS; SARS;
D O I
10.1016/j.slasd.2024.100160
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Four years after the beginning of the COVID-19 pandemic, it is important to reflect on the events that have occurred during that time and the knowledge that has been gained. The response to the pandemic was rapid and highly resourced; it was also built upon a foundation of decades of federally funded basic and applied research. Laboratories in government, pharmaceutical, academic, and non-profit institutions all played roles in advancing pre-2020 discoveries to produce clinical treatments. This perspective provides a summary of how the development of high-throughput screening methods in a biosafety level 3 (BSL-3) environment at Southern Research Institute (SR) contributed to pandemic response efforts. The challenges encountered are described, including those of a technical nature as well as those of working under the pressures of an unpredictable virus and pandemic.
引用
收藏
页数:15
相关论文
共 54 条
[1]   Targeting Chikungunya Virus Replication by Benzoannulene Inhibitors [J].
Ahmed, S. Kaleem ;
Haese, Nicole N. ;
Cowan, Jaden T. ;
Pathak, Vibha ;
Moukha-Chafiq, Omar ;
Smith, Valerie J. ;
Rodzinak, Kevin J. ;
Ahmad, Fahim ;
Zhang, Sixue ;
Bonin, Kiley M. ;
Streblow, Aaron D. ;
Streblow, Cassilyn E. ;
Kreklywich, Craig N. ;
Morrison, Clayton ;
Sarkar, Sanjay ;
Moorman, Nathaniel ;
Sander, Wes ;
Allen, Robbie ;
DeFilippis, Victor ;
Tekwani, Babu L. ;
Wu, Mousheng ;
Hirsch, Alec J. ;
Smith, Jessica L. ;
Tower, Nichole A. ;
Rasmussen, Lynn ;
Bostwick, Robert ;
Maddry, Joseph A. ;
Ananthan, Subramaniam ;
Gerdes, John M. ;
Augelli-Szafran, Corinne E. ;
Suto, Mark J. ;
Morrison, Thomas E. ;
Heise, Mark T. ;
Streblow, Daniel N. ;
Pathak, Ashish K. .
JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (08) :4762-4786
[2]   High-throughput screening for inhibitors of Mycobacterium tuberculosis H37Rv [J].
Ananthan, Subramaniam ;
Faaleolea, Ellen R. ;
Goldman, Robert C. ;
Hobrath, Judith V. ;
Kwong, Cecil D. ;
Laughon, Barbara E. ;
Maddry, Joseph A. ;
Mehta, Alka ;
Rasmussen, Lynn ;
Reynolds, Robert C. ;
Secrist, John A., III ;
Shindo, Nice ;
Showe, Dustin N. ;
Sosa, Melinda I. ;
Suling, William J. ;
White, E. Lucile .
TUBERCULOSIS, 2009, 89 (05) :334-353
[3]  
[Anonymous], Public health and social measures for health emergencies and pandemics in the EU/EEA: recommendations for strengthening preparedness planning 2024 Report
[4]   High-throughput screening of stabilizers for respiratory syncytial virus - Identification of stabilizers and their effects on the conformational thermostability of viral particles [J].
Ausar, Salvador F. ;
Espina, Marianela ;
Brock, Julie ;
Thyagarayapuran, Nagaraian ;
Repetto, Robert ;
Khandke, Lakshmi ;
Middaugh, C. Russell .
HUMAN VACCINES, 2007, 3 (03) :94-103
[5]  
Barnard Dale L., 2004, Antiviral Chemistry & Chemotherapy, V15, P15
[6]   Early Emergence Phase of SARS-CoV-2 Delta Variant in Florida, US [J].
Cella, Eleonora ;
Ali, Sobur ;
Schmedes, Sarah E. ;
Magalis, Brittany Rife ;
Marini, Simone ;
Salemi, Marco ;
Blanton, Jason ;
Azarian, Taj .
VIRUSES-BASEL, 2022, 14 (04)
[7]   Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2 [J].
Chen, Catherine Z. ;
Shinn, Paul ;
Itkin, Zina ;
Eastman, Richard T. ;
Bostwick, Robert ;
Rasmussen, Lynn ;
Huang, Ruili ;
Shen, Min ;
Hu, Xin ;
Wilson, Kelli M. ;
Brooks, Brianna M. ;
Guo, Hui ;
Zhao, Tongan ;
Klump-Thomas, Carleen ;
Simeonov, Anton ;
Michael, Samuel G. ;
Lo, Donald C. ;
Hall, Matthew D. ;
Zheng, Wei .
FRONTIERS IN PHARMACOLOGY, 2021, 11
[8]   Comparative tropism, replication kinetics, and cell damage profiling of SARS-CoV-2 and SARS-CoV with implications for clinical manifestations, transmissibility, and laboratory studies of COVID-19: an observational study [J].
Chu, Hin ;
Chan, Jasper Fuk-Woo ;
Yuen, Terrence Tsz-Tai ;
Shuai, Huiping ;
Yuan, Shuofeng ;
Wang, Yixin ;
Hu, Bingjie ;
Yip, Cyril Chik-Yan ;
Tsang, Jessica Oi-Ling ;
Huang, Xiner ;
Chai, Yue ;
Yang, Dong ;
Hou, Yuxin ;
Chik, Kenn Ka-Heng ;
Zhang, Xi ;
Fung, Agnes Yim-Fong ;
Tsoi, Hoi-Wah ;
Cai, Jian-Piao ;
Chan, Wan-Mui ;
Ip, Jonathan Daniel ;
Chu, Allen Wing-Ho ;
Zhou, Jie ;
Lung, David Christopher ;
Kok, Kin-Hang ;
To, Kelvin Kai-Wang ;
Tsang, Owen Tak-Yin ;
Chan, Kwok-Hung ;
Yuen, Kwok-Yung .
LANCET MICROBE, 2020, 1 (01) :E14-E23
[9]   HTS-Driven Discovery of New Chemotypes with West Nile Virus Inhibitory Activity [J].
Chung, Dong Hoon ;
Jonsson, Colleen B. ;
Maddox, Clinton ;
McKellip, Sara N. ;
Moore, Blake. P. ;
Heil, Marintha ;
White, E. Lucile ;
Ananthan, Subramaniam ;
Li, Qianjun ;
Feng, Shuang ;
Rasmussen, Lynn .
MOLECULES, 2010, 15 (03) :1690-1704
[10]   Discovery of a Novel Compound with Anti-Venezuelan Equine Encephalitis Virus Activity That Targets the Nonstructural Protein 2 [J].
Chung, Dong-Hoon ;
Jonsson, Colleen B. ;
Tower, Nichole A. ;
Chu, Yong-Kyu ;
Sahin, Ergin ;
Golden, Jennifer E. ;
Noah, James W. ;
Schroeder, Chad E. ;
Sotsky, Julie B. ;
Sosa, Melinda I. ;
Cramer, Daniel E. ;
McKellip, Sara N. ;
Rasmussen, Lynn ;
White, E. Lucile ;
Schmaljohn, Connie S. ;
Julander, Justin G. ;
Smith, Jeffrey M. ;
Filone, Claire Marie ;
Connor, John H. ;
Sakurai, Yasuteru ;
Davey, Robert A. .
PLOS PATHOGENS, 2014, 10 (06)